Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial

S. Danson, M. Ranson, O. Denneny, J. Cummings, T. H. Ward

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science